Most drug discovery and development companies rely on licensing to fund their technology development programmes, either directly or as an exit for investors. We have complied a report that represents an attempt to put a figure on the amount of money that is circulating in the drug discovery and development economy. (full report available see bottom of article)

Our research led us to believe that:

The appetite for deals appears to have grown over the past 10 years but stabilised in recent years and this trend is followed by most of the individual indication groups.

The amount of money circulating in the drug discover and development economy in 2007 was roughly US$340bn, the level is pretty much the same as 2006, but an increase from 2005.

Get the full report!

This report makes interesting reading and should you wish to view the report in full, just drop a message in the contact form below with your e-mail and I will send you a password so you access the pdf from the reports section of the site (see top link). The report contains comparisons by indication group on deal volume and deal values with a brief outline of how we came to the global figure.

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology), we work with our clients to define a development target, define a development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch using the contact form or email Damien at damien.bove@idaconsultants.com